Will side effect information ever be one click away?
After years of mulling over social media uses, the Food and Drug Administration plans to study the whether a tweet promoting a prescription drug with a link to risk information is an acceptable way to reach consumers.
The plan is the latest in an ongoing, but drawn-out, effort by the agency to provide the pharmaceutical industry with guidelines for using social media to promote medicines. The FDA, in fact, two years ago issued a draft guidance about the use of social media platforms, such as Twitter, but never actually addressed if drug makers could employ links to convey important side effect data.
About the Author Reprints
